|
Dermatology 1996;193(1):65-66
Interferon-induced vitiligo in a patient with chronic viral hepatitis C
infection.
Simsek H, Savas C, Akkiz H, Telatar H Hacettepe University Medical
School, Department of Internal Medicine, Ankara, Turkey.
Vitiligo is an autoimmune disease characterized by depigmentation of the skin
due to destruction of melanocytes. Interferons have been used for the treatment
of chronic hepatitis C and some malignancies. We report interferon alpha-2a-induced
vitiligo in a male patient with chronic active hepatitis C. All skin lesions
disappeared completely without requiring therapy after discontinuation of interferon.
This case suggests that vitiligo may be developed during interferon therapy
as a side effect.
Publication Types:
Review Review of reported cases
PMID: 8864627, UI: 97018010
table Of Contents
|
